跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,970 条关于
“C-CAR031/AZD7003”
全部
13,970
临床试验
6,895
药物
1,757
机构
3,018
资讯
2,300
上个月
AbelZeta and AstraZeneca's Armored GPC3 CAR-T Therapy Shows Promising Efficacy in Advanced Hepatocellular Carcinoma, Published in Nature
2年前
Imfinzi Plus Imjudo Shows Unprecedented Survival in Advanced Liver Cancer
去年
Advancements in Clostridioides difficile Treatment and Prevention Highlighted in 2024
去年
Akeso's Phase 3 Trial Begins for Ivonescimab and Ligufalimab Combination in Head and Neck Cancer
去年
FDA Approvals in 2024: NASH Treatment, DMD Therapy, Novel Schizophrenia Drug, and Breast Cancer Advancement
去年
NIH to Sponsor Phase 1 Trial of Fzata's Novel Oral Biologic FZ002 for C. difficile Treatment
去年
HepaRegeniX Secures €15 Million to Advance HRX-215 for Liver Regeneration
去年
Key Infectious Disease Updates: C. difficile, Salmonella Outbreak, Hepatitis C Treatment, and More
2年前
ArsenalBio Secures $325 Million in Series C Funding to Advance CAR T-Cell Therapies for Solid Tumors
去年
Javara Secures Series C Funding to Expand Community-Based Clinical Trial Access into Oncology and CNS
第 1 页,共 230 页
上一页
下一页